in this issue
Regions :: India/Pakistan
European regulatory authorities to reinstate GMP certificate for Ranbaxy’s API plant at Toansa
12:23 PM MDT | June 5, 2014 | Deepti Ramesh
After assessing of Ranbaxy Laboratories' (Gurgaon, India) active pharmaceutical ingredient (API) manufacturing facility at Toansa, India, European regulatory authorities say the company has instituted corrective measures and are satisfied that the measures are sufficient to ensure GMP-compliant manufacture of products at the site, the European Medicines Agency (EMA; London) announced today. As a consequence, EU authorities will reinstate the GMP certificate that was suspended in January, EMA says. The assessment follows a US FDA inspection, which...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee